iShares MSCI United Kingdom ETF (EWU)

26.51 -0.18  -0.67% NYSE Arca Aug 7, 20:00 USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 26.39
Discount or Premium to NAV 0.45%
Turnover Ratio 11.00%
1 Year Fund Level Flows 479.92M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.24% 0.88% -- --
3M 8.04% 7.53% -- --
6M -17.52% -18.38% -- --
YTD -21.08% -21.21% -- --
1Y -8.91% -8.81% -- --
3Y -4.55% -4.62% -- --
5Y -2.64% -2.63% -- --
10Y 2.07% 2.12% -- --
15Y 1.72% 1.71% -- --
20Y 1.81% 1.87% -- --
As of Aug. 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.88% 0.93% 0.05%
Stock 98.51% 98.51% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.62% 0.62% 0.00%
As of Aug. 7, 2020

Region Exposure

Americas 1.10%
North America 1.10%
Latin America 0.00%
Greater Europe 98.90%
United Kingdom 97.40%
Europe Developed 1.50%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.21%
As of Aug. 7, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 10.76%
Communication Services 6.88%
Consumer Cyclical 5.60%
Consumer Defensive 20.43%
Energy 10.68%
Financial Services 16.86%
Healthcare 14.36%
Industrials 8.34%
Real Estate 1.31%
Technology 0.78%
Utilities 3.98%
As of Aug. 7, 2020

Stock Market Capitalization

Giant 47.06%
Large 30.53%
Medium 22.25%
Small 0.16%
Micro 0.00%
As of Aug. 7, 2020

Stock Style Exposure

Large Cap Value 45.58%
Large Cap Blend 28.39%
Large Cap Growth 3.62%
Mid Cap Value 9.95%
Mid Cap Blend 6.13%
Mid Cap Growth 6.17%
Small Cap Value 0.16%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Aug. 7, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
AZN AstraZeneca PLC 7.59% -- --
GSK GlaxoSmithKline PLC 5.33% -- --
HSBA HSBC Holdings PLC 4.52% -- --
DGE Diageo PLC 4.10% -- --
BP. BP PLC 3.97% -- --
BATS British American Tobacco PLC 3.90% -- --
RB. Reckitt Benckiser Group PLC 3.67% -- --
ULVR Unilever PLC 3.62% -- --
RIO Rio Tinto PLC 3.58% -- --
RDSA Royal Dutch Shell PLC Class A 3.25% -- --
As of Aug. 7, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the MSCI United Kingdom Index. The fund will at all times invest at least 90% of its assets in the securities of its underlying index and in depositary receipts representing securities in its underlying index. The underlying index primarily consists of stocks traded on the London Stock Exchange. The underlying index will include large- and mid-capitalization companies and may change over time. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name Miscellaneous Region
Prospectus Objective Europe Stock
Fund Owner Firm Name iShares
Benchmark Index
MSCI United Kingdom NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 4.30 yrs
Amy Whitelaw 1.59 yrs
Greg Savage 12.59 yrs
Jennifer Hsui 7.59 yrs
Rachel Aguirre 1.59 yrs

Net Fund Flows

1M 54.97M
3M 292.75M
6M 75.34M
YTD 169.28M
1Y 479.92M
3Y -47.40M
5Y -469.39M
10Y 2.017B
As of July 31, 2020

Risk Info

Beta (5Y) 0.9825
Max Drawdown (All) 64.00%
Historical Sharpe Ratio (10Y) 0.1729
Historical Sortino (All) 0.2923
30-Day Rolling Volatility 18.47%
Daily Value at Risk (VaR) 1% (All) 4.05%
Monthly Value at Risk (VaR) 1% (All) 16.30%

Fundamentals

Dividend Yield TTM (8-7-20) 3.75%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 17.33
Weighted Average Price to Sales Ratio 0.8998
Weighted Average Price to Book Ratio 1.375
Weighted Median ROE 16.46%
Weighted Median ROA 3.89%
Forecasted Dividend Yield 5.98%
Forecasted PE Ratio 16.50
Forecasted Price to Sales Ratio 0.8755
Forecasted Price to Book Ratio 1.220
Number of Holdings 95
As of Aug. 7, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 5.94%
Forecasted Book Value Growth 2.97%
Forecasted Cash Flow Growth 12.10%
Forecasted Earnings Growth 2.20%
Forecasted Revenue Growth 1.45%
As of Aug. 7, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 3/12/1996
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 12/30/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.